Ketamine Troche

Ketamine troches provide a sophisticated delivery system for this potent NMDA receptor antagonist, facilitating rapid neuroplasticity and glutamate modulation to address treatment-resistant mood disorders and chronic pain syndromes. The formulation leverages the synergistic relationship between the active medicinal agent and a specialized mucoadhesive base, ensuring optimal mucosal contact and a steady release profile for a consistent therapeutic effect. By utilizing the buccal or sublingual route, this dosage form bypasses first-pass hepatic metabolism, significantly enhancing bioavailability while offering a non-invasive, patient-friendly alternative to parenteral administration.